Business
Earlier this year, the prescription digital therapeutics company said it would put programs related to cognitive health outside of ADHD on hold.
According to a filing with the Securities and Exchange Commission, the company still plans to hire "to support its service capacity needs and growth expectations."
Transcarent will purchase 98point6's virtual care platform and care business. After the deal, 98point6 will focus on licensing its software to third-party providers.
In a post on LinkedIn, Color CEO Othman Laraki said the company would focus on its core lines of business, including testing and telehealth infrastructure for government programs, and its prevention tools for employers and healthcare purchasers.
The funds will be used to open new clinics in the U.S.
Drug-discovery platform TandemAI, sleep-care platform BetterNight, health-monitoring system Xandar Kardian and AR/VR platform Healium also announced funding rounds.
The digital health company reported $184.1 million in revenue for Q4, a 14% decline from the same period in 2021.
The mental health platform let go of 15% of its workforce.
The company reported $526.9 million in revenue last year compared with $271.9 million in 2021.
Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.